title: [Malignant hypertension--case report].
abstract: The authors present the case of a 25 year old man who presented in our clinic because of an important decreasing of his visual acuity at AO (OS > OD) which had installed progressively 3 months before his presentation. After the FAO examination there were found important changes with the bilateral presence of the papilledema, macular edema, hemorrhages in flame on the route of big vessels and the presence of multiple hard and soft exudates. After the clinical examination, it was found the presence of arterial hypertension TA = 240/140. The investigations from the laboratory pointed out important changes of the values of urea and creatinine, values which are characteristic for advanced stages of IR. After setting up the hypertensive treatment and the tension re-balancing it was found a slightly improvement of the ocular symptomatology, the patient prognosis remains reserved because of advanced renal lesions. The purpose of this case presentation is to make sensible doctors in general and eye doctors in particular about the importance of general clinical examination in establishing the final diagnosis. We mention that before presenting in our clinic, the patient did various ophthalmologic checking and complementary investigations suspecting a retinal vasculitis.
authors.affiliation: Clinica de Oftalmologie, Spitalul Clinic de Urgenţă Militar Central Bucureşti.
authors.forename: Silvia
authors.initials: S
authors.lastname: Chiotoroiu
authors.forename: I
authors.initials: I
authors.lastname: Stefaniu
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005654:Fundus Oculi; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008269:Macular Edema / Q000209:etiology; D008297:Male; D010211:Papilledema / Q000209:etiology; D011379:Prognosis; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012164:Retinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012166:Retinal Hemorrhage / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide